Metropolitan Life Insurance Company (MetLife)’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,211
| Closed | -$27.3K | – | 137 |
|
|
2024
Q1 | $27.3K | Hold |
1,211
| – | – | ﹤0.01% | 1704 |
|
|
2023
Q4 | $25.9K | Hold |
1,211
| – | – | ﹤0.01% | 1799 |
|
|
2023
Q3 | $21.8K | Hold |
1,211
| – | – | ﹤0.01% | 1855 |
|
|
2023
Q2 | $24.6K | Hold |
1,211
| – | – | ﹤0.01% | 1819 |
|
|
2023
Q1 | $26.4K | Hold |
1,211
| – | – | ﹤0.01% | 1741 |
|
|
2022
Q4 | $37.5K | Hold |
1,211
| – | – | ﹤0.01% | 1642 |
|
|
2022
Q3 | $30.9K | Hold |
1,211
| – | – | ﹤0.01% | 1787 |
|
|
2022
Q2 | $24.6K | Hold |
1,211
| – | – | ﹤0.01% | 1940 |
|
|
2022
Q1 | $30K | Sell |
1,211
-4,419
| -78% | -$109K | ﹤0.01% | 1884 |
|
|
2021
Q4 | $196K | Hold |
5,630
| – | – | ﹤0.01% | 2043 |
|
|
2021
Q3 | $153K | Sell |
5,630
-2,367
| -30% | -$64.2K | ﹤0.01% | 2278 |
|
|
2021
Q2 | $207K | Buy |
7,997
+546
| +7% | +$14.2K | ﹤0.01% | 2111 |
|
|
2021
Q1 | $161K | Sell |
7,451
-703
| -9% | -$15.2K | ﹤0.01% | 2166 |
|
|
2020
Q4 | $175K | Hold |
8,154
| – | – | ﹤0.01% | 2017 |
|
|
2020
Q3 | $120K | Hold |
8,154
| – | – | ﹤0.01% | 2110 |
|
|
2020
Q2 | $182K | Hold |
8,154
| – | – | ﹤0.01% | 1865 |
|
|
2020
Q1 | $115K | Hold |
8,154
| – | – | ﹤0.01% | 1948 |
|
|
2019
Q4 | $133K | Hold |
8,154
| – | – | ﹤0.01% | 2166 |
|
|
2019
Q3 | $285K | Buy |
8,154
+1,012
| +14% | +$35.4K | ﹤0.01% | 1632 |
|
|
2019
Q2 | $403K | Buy |
7,142
+197
| +3% | +$11.1K | 0.01% | 1441 |
|
|
2019
Q1 | $507K | Hold |
6,945
| – | – | 0.01% | 1288 |
|
|
2018
Q4 | $443K | Buy |
6,945
+1,154
| +20% | +$73.6K | 0.01% | 1269 |
|
|
2018
Q3 | $578K | Hold |
5,791
| – | – | 0.01% | 1256 |
|
|
2018
Q2 | $411K | Hold |
5,791
| – | – | 0.01% | 1450 |
|
|
2018
Q1 | $603K | Buy |
5,791
+134
| +2% | +$13.9K | 0.01% | 1156 |
|
|
2017
Q4 | $570K | Sell |
5,657
-3,003
| -35% | -$303K | 0.01% | 1201 |
|
|
2017
Q3 | $303K | Buy |
+8,660
| New | +$303K | ﹤0.01% | 2024 |
|